Literature DB >> 20051242

Deficiency of the negative immune regulator B7-H1 enhances inflammation and neuropathic pain after chronic constriction injury of mouse sciatic nerve.

Nurcan Uçeyler1, Kerstin Göbel, Sven G Meuth, Sonja Ortler, Guido Stoll, Claudia Sommer, Heinz Wiendl, Christoph Kleinschnitz.   

Abstract

Peripheral nerve injury induces a profound local inflammatory response that involves T cells and macrophages and augments the generation of neuropathic pain. The mechanisms underlying immune cell activation or inhibition in the peripheral nervous system, however, are unknown. The co-inhibitory molecule B7-H1 (PD-L1, CD274) attenuates immune cell proliferation and cytokine production and protects from inflammation-induced tissue damage. We analyzed the temporal gene expression profile of B7-H1 and different cytokines after chronic constriction injury (CCI) of the sciatic nerve, a lesion paradigm inducing neuropathic pain, by quantitative real-time polymerase chain reaction and immunohistochemistry in B7-H1(-/-) mice and wild-type (WT) controls. B7-H1 mRNA was markedly induced in WT nerves after CCI, and macrophages could be identified as major B7-H1 source. The proinflammatory mediators tumor necrosis factor alpha (TNFalpha) and monocyte chemoattractant protein-1 (MCP-1) displayed a strong, but transient expression in degenerating nerves on day 1 after CCI in WT mice, while a biphasic expression peak on day 1 and day 28 was found in B7-H1(-/-) mice. Overall, TNFalpha and MCP-1 levels in B7-H1-deficient nerves dramatically exceeded those in WT controls. In contrast, induction of the anti-inflammatory cytokine interleukin(IL)-10 was restricted to WT nerves. The observation that B7-H1 deficiency enhances inflammation upon CCI was further corroborated by immunohistochemistry showing increased numbers of T cells and macrophages in injured nerves from B7-H1(-/-) mice. Interestingly, mechanical hyperalgesia was more pronounced in the absence of B7-H1. Our study identifies B7-H1 as an important suppressor of the inflammatory response and neuropathic pain occurring after peripheral nerve injury. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20051242     DOI: 10.1016/j.expneurol.2009.12.026

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  13 in total

1.  Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1): Analysis in 5536 Cases Revealed Consistent Expression in Trophoblastic Tumors.

Authors:  Shingo Inaguma; Zengfeng Wang; Jerzy Lasota; Maarit Sarlomo-Rikala; Peter A McCue; Hiroshi Ikeda; Markku Miettinen
Journal:  Am J Surg Pathol       Date:  2016-08       Impact factor: 6.394

Review 2.  Animal models of autoimmune neuropathy.

Authors:  Betty Soliven
Journal:  ILAR J       Date:  2014

3.  PD-L1 inhibits acute and chronic pain by suppressing nociceptive neuron activity via PD-1.

Authors:  Gang Chen; Yong Ho Kim; Hui Li; Hao Luo; Da-Lu Liu; Zhi-Jun Zhang; Mark Lay; Wonseok Chang; Yu-Qiu Zhang; Ru-Rong Ji
Journal:  Nat Neurosci       Date:  2017-05-22       Impact factor: 24.884

Review 4.  Neuroinflammation and Central Sensitization in Chronic and Widespread Pain.

Authors:  Ru-Rong Ji; Andrea Nackley; Yul Huh; Niccolò Terrando; William Maixner
Journal:  Anesthesiology       Date:  2018-08       Impact factor: 7.892

5.  Glial NF-κB inhibition alters neuropeptide expression after sciatic nerve injury in mice.

Authors:  Yan Ping Zhang; Eugene S Fu; Jacqueline Sagen; Roy C Levitt; Keith A Candiotti; John R Bethea; Roberta Brambilla
Journal:  Brain Res       Date:  2011-02-23       Impact factor: 3.252

6.  Novel thioredoxin reductase inhibitor butaselen inhibits tumorigenesis by down-regulating programmed death-ligand 1 expression.

Authors:  Qiao Zou; Yi-Fan Chen; Xiao-Qing Zheng; Suo-Fu Ye; Bin-Yuan Xu; Yu-Xi Liu; Hui-Hui Zeng
Journal:  J Zhejiang Univ Sci B       Date:  2018 Sept.       Impact factor: 3.066

7.  In vivo USPIO magnetic resonance imaging shows that minocycline mitigates macrophage recruitment to a peripheral nerve injury.

Authors:  Pejman Ghanouni; Deepak Behera; Jin Xie; Xiaoyuan Chen; Michael Moseley; Sandip Biswal
Journal:  Mol Pain       Date:  2012-06-28       Impact factor: 3.395

8.  IL-4 deficiency is associated with mechanical hypersensitivity in mice.

Authors:  Nurcan Üçeyler; Tengü Topuzoğlu; Peter Schiesser; Saskia Hahnenkamp; Claudia Sommer
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

Review 9.  microRNAs in nociceptive circuits as predictors of future clinical applications.

Authors:  Michaela Kress; Alexander Hüttenhofer; Marc Landry; Rohini Kuner; Alexandre Favereaux; David Greenberg; Josef Bednarik; Paul Heppenstall; Florian Kronenberg; Marzia Malcangio; Heike Rittner; Nurcan Uçeyler; Zlatko Trajanoski; Peter Mouritzen; Frank Birklein; Claudia Sommer; Hermona Soreq
Journal:  Front Mol Neurosci       Date:  2013-10-17       Impact factor: 5.639

10.  Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism.

Authors:  L Di Cesare Mannelli; G D'Agostino; A Pacini; R Russo; M Zanardelli; C Ghelardini; A Calignano
Journal:  Mediators Inflamm       Date:  2013-02-25       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.